Turkey Tail Mushroom: Cancer Claims vs Reality

Turkey tail (Trametes versicolor, also written Coriolus versicolor) has been used in traditional Chinese medicine for centuries and is now one of the most heavily marketed medicinal mushroom supplements in Western retail. The marketing often implies — or outright says — that turkey tail can prevent or treat cancer. That claim goes well beyond what the science supports.

The Active Compounds and What They Actually Do

Turkey tail contains two polysaccharide complexes: polysaccharide-K (PSK, sold in Japan as Krestin) and polysaccharide-peptide (PSP). PSK has been used in Japan since 1977 as an adjunct to standard cancer therapy — alongside surgery and chemotherapy, not in place of them. A 2017 network meta-analysis of 23 trials in 10,684 patients found that PSK added to chemotherapy significantly improved 1- to 5-year overall survival in colorectal and gastric cancers, with no increase in side effects. A separate 2007 individual-patient meta-analysis of curative gastric-cancer resections (8,009 patients) reported a hazard ratio of 0.88 (95% CI 0.79–0.98) for survival with PSK. This is real evidence — but for purified PSK specifically, in cancer patients, alongside chemotherapy, in mostly Japanese populations.

The Retail Product Gap

What this evidence does not support: turkey tail supplements preventing cancer in healthy people, replacing conventional therapy, or off-the-shelf retail products that have not standardized PSK content being equivalent to the pharmaceutical PSK extract used in Japan. Most US retail turkey tail supplements do not verify PSK content or replicate the dosing schedules used in trials. The 2012 Bastyr/NIH-NCI funded phase 1 trial by Torkelson and colleagues (n=11, 9 completers) tested 3, 6, or 9 g/day after radiation in breast cancer patients. The 6 g/day dose increased natural killer cell activity, but the study was tiny, designed to assess safety, and not powered to show clinical benefit.

Safety

Turkey tail is generally well tolerated at typical supplement doses. Patients undergoing chemotherapy, immunotherapy, or transplant immunosuppression should consult their oncology team before adding any immune-modulating supplement, since interactions with cancer regimens are theoretically possible.